RMAT Spectrum Services

 

Through our Regenerative Medicine Advanced Therapy ("RMAT") Spectrum Services program, we use a specialized, strategic approach that employs a team to do the heavy lifting for a company or provider, helping them confidently and efficiently engage in dialog with regulators to seek fast-track approval to market their therapeutic or device innovations. Several such efficient pathways to approval exist,, including FDA’s RMAT designation, made possible in part through the work of our Founder, Doug Oliver.